A Refractory Case of CDKN2A/B Loss Metastatic Intrahepatic Cholangiocarcinoma Achieving a Partial Response After First-Line Treatment with Palbociclib

Intrahepatic cholangiocarcinoma (ICC) is a highly aggressive and malignant subtype of biliary duct tumors. The poor prognosis of advanced ICC brings great challenges to clinical treatment, and chemotherapy-based therapy remains the standard first-line regimen. In recent years, the development of cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Weiming, Wang, Chuan, Zhong, Xuefeng, Zheng, Yating, Chen, Tingting, Huang, Mengli, Su, Shuying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869796/
https://www.ncbi.nlm.nih.gov/pubmed/36698435
http://dx.doi.org/10.2147/OTT.S390458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869796/
https://www.ncbi.nlm.nih.gov/pubmed/36698435
http://dx.doi.org/10.2147/OTT.S390458

Ejemplares similares